Casandra
Casandra Test Code NG70522Version 1 (DRAFT)
Performing Lab
FLT3 Mutation Analysis
Also known as: FLT3, FLT3 TKD, FLT3 ITD
Clinical Use
Order TestUse
Testing for FLT3 and other gene mutations in AML patients with intermediate‑risk cytogenetic abnormalities can improve risk stratification. The presence of an FLT3 mutation in a patient with AML implies aggressive disease.
Special Instructions
Positive results identify presence of TKD mutations or report ITD results quantitatively as allelic ratio.
Limitations
Not provided.
Test Details
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
FLT3
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Bone Marrow
Volume
2 mL
Minimum Volume
Not provided
Container
EDTA tube
Storage Instructions
Refrigerate before shipping; ship same day; do not freeze. Use cold pack not in direct contact.